While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

The prevalence of diabetes is increasing faster in some low-income countries than elsewhere in the world, generating concerns ...

Sotagliflozin, recently approved by the FDA for treating type 2 diabetes and kidney disease in patients with cardiovascular ...

Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...

A recent study from the FINEARTS-HF trial revealed that finerenone, which is an oral mineralocorticoid receptor antagonist, ...

aDepartment of Paediatrics and Department of Pathology, Immunology and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL, USA ...